Biogen Acquires Ionis’ Spinal Muscular Atrophy Candidate As Spinraza Loses Its Shine

Pays $60m Upfront

 
• By Ayisha Sharma
  
Box of Spinraza in the foreground, young child in the background
BIIB115 Is Set To Replace Spinraza, Which Could Be Left On The Shelf • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business